By Monica Heger

Intelligent Bio-Systems is developing a low-cost sequencing system that it claims is particularly suited for the clinical market and plans to commercially launch the system in 2012.

Steven Gordon, CEO of Waltham, Mass.-based IBS, disclosed the company's plans for the system at this month's X-Gen Congress meeting in San Diego. He said the company plans to line up early-access customers in the third or fourth quarter of this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.